recodetx.comHealthcareFounded: 2015Funding to Date: $323.57MM
Develops precision genetic medicines and therapies focused on Cystic Fibrosis, Primary Ciliary Dyskinesia and various cancers and central nervous system diseases.
View Enterprise Value for ReCode Therapeutics.